Earnings Call · Q2 FY2022·2022-08-10

Q2 22EPS +5.48%·Rev n/aQ1 22EPS +2.94%·Rev n/aQ4 21EPS 0.00%·Rev n/aQ3 21EPS -94.52%·Rev n/a⚠ consensus missing

Whitehawk Therapeutics, Inc. WHWK

Marcy Graham — Investor Relations or Communications

Neil Desai — President and CEO

Brendan Delaney — Chief Operating Officer

Loretta Itri — Chief Medical Officer or Clinical Development Lead

Scott Giacobello — Chief Financial Officer

−1.5%1d on move date−3.6% vs SPY3d−1.0%5d−4.3%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more WHWK calls or request research access.

More WHWK calls Browse calls Request research access